PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 20 filers reported holding PROQR THRAPEUTICS N V in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,900,000 | -76.2% | 346,148 | -57.0% | 0.24% | -63.8% |
| Q4 2019 | $7,978,000 | +51.4% | 805,000 | -12.0% | 0.66% | -19.3% |
| Q3 2019 | $5,270,000 | +23.2% | 915,000 | +94.7% | 0.81% | +39.1% |
| Q2 2019 | $4,277,000 | +62.3% | 470,000 | +147.4% | 0.58% | +142.7% |
| Q1 2019 | $2,635,000 | -50.9% | 190,000 | -44.1% | 0.24% | -60.2% |
| Q4 2018 | $5,365,000 | -30.5% | 340,000 | -14.7% | 0.60% | -31.7% |
| Q3 2018 | $7,716,000 | +114.1% | 398,749 | -19.2% | 0.89% | +78.3% |
| Q2 2018 | $3,604,000 | +78.0% | 493,749 | -25.0% | 0.50% | +61.9% |
| Q1 2018 | $2,025,000 | +18.5% | 658,500 | +24.2% | 0.31% | +52.7% |
| Q4 2017 | $1,709,000 | -33.5% | 530,000 | 0.0% | 0.20% | -45.2% |
| Q3 2017 | $2,571,000 | +49.8% | 530,000 | +60.6% | 0.37% | +25.7% |
| Q2 2017 | $1,716,000 | +4.0% | 330,000 | 0.0% | 0.29% | -9.6% |
| Q1 2017 | $1,650,000 | +68.4% | 330,000 | +65.0% | 0.32% | +30.2% |
| Q4 2016 | $980,000 | -24.7% | 200,000 | +33.3% | 0.25% | +29.8% |
| Q4 2015 | $1,302,000 | -53.8% | 150,000 | +15.4% | 0.19% | -60.2% |
| Q4 2014 | $2,817,000 | -18.1% | 130,000 | -35.0% | 0.48% | +12.9% |
| Q3 2014 | $3,438,000 | – | 200,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |